US-based healthcare technology company AirStrip has secured a $50m growth credit facility and additional equity funding from OrbiMed to expedite its growth strategy.

The proceeds will support the company’s expansion in response to the rising demand for its offerings in clinical surveillance, patient monitoring, alarm management, and decision support.

For this transaction, BTIG served as the exclusive placement agent, as well as strategic adviser.

The credit facility will also be directed towards advancing product innovation,
expanding go-to-market initiatives, and enabling rapid deployment across hospitals and healthcare systems across the country.

AirStrip currently partners with more than 675 hospitals in the US, allowing clinicians to access near real-time clinical data securely via the internet and mobile devices.

With the new funding, the company will be able to continue its expansion into the broader hospital market of over 6,000 facilities, supporting further investment in customer implementation, product development, and workforce growth.

AirStrip’s product portfolio encompasses continuous, mobile-enabled monitoring across multiple care settings.

Its clinical decision support solutions deliver digital protocol management, transforming fragmented data into actionable insights that enable timely intervention.

AirStrip CEO Haris Naseem said: “This funding will accelerate our transformation of how clinicians access and act on critical clinical information. We're unifying fragmented data and delivering timely, actionable insights to facilitate improved decision-making and enhanced patient safety at every stage of care.”

OrbiMed general partner Matthew Rizzo said: “OrbiMed seeks to partner with companies that deliver meaningful, sustainable impacts in healthcare. AirStrip is a proven leader with tremendous potential, and we're excited to participate in their next phase of growth and innovation.”